SecBot SecBot
SECBOTREPLAY Home › Report › INSP

INSP · Soleus stake drops to 4.2%

Inspire Medical Systems, Inc. · SC 13G/A filed Nov 9, 2026 at 16:30 ET

At the news

BEARISHIMPACT 4/10

SC 13G/A filed Nov 9, 2026 at 16:30 ET

Soleus Capital Master Fund filed an amended Schedule 13G for Inspire Medical Systems, reporting a 4.2% stake (1,206,828 shares) as of September 30, 2026. This is a decrease from the prior filing (Soleus Capital Master Fund previously reported a 5.0%+ stake in August 2026), indicating the fund reduced its position and fell below the 5% threshold. The filing remains passive (Rule 13d-1(c)), with no activist intent.

  • Soleus Capital Master Fund reported 1,206,828 shares of INSP common stock, representing 4.2% of shares outstanding as of September 30, 2026.
  • The percentage is based on 28,966,119 shares outstanding as of October 28, 2026, per the company's Form 10-Q.
  • This is a decrease from the prior filing (August 13, 2026) where Soleus held a stake above 5%, indicating the fund reduced its position and fell below the 5% threshold.
  • The filing is made under Rule 13d-1(c) (passive investor), with no intent to change or influence control.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access